5876:TWSEShanghai Commercial & Savings Bank, Ltd. Analysis
Data as of 2026-03-11 - not real-time
NT$39.15
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The Shanghai Commercial & Savings Bank trades at TWD 39.15, which is more than six times its DCF‑derived fair value of 6.3, flagging a clear overvaluation despite a trailing PE of 12.8 that sits comfortably below the industry average of 17.1. Technical signals are bearish: the price is under the 20‑day (39.6) and 50‑day (39.9) moving averages, the MACD histogram is negative, and the RSI hovers around 45, indicating no momentum. Volatility over the past 30 days is moderate at 14 %, but the beta is exceptionally low at 0.07, suggesting the stock moves little with the broader market. Support sits near 37.6 while resistance is around 40.85, leaving limited upside in the near term. The bank offers a high dividend yield of 4.6 % with a payout ratio of 59 %, yet its net‑debt position (debt 124 B vs cash 65 B) raises concerns about the sustainability of that payout. Revenue growth of 11.6 % and a solid operating margin of 32 % provide earnings support, but a modest ROE of 6.2 % limits value‑creation potential. Geographic exposure across Taiwan, Hong Kong, Vietnam, Singapore, and mainland China adds diversification but also introduces medium‑level geopolitical and regulatory risk.
Given the combination of bearish price action, a valuation gap relative to DCF, and debt‑related dividend sustainability questions, the short‑term outlook leans toward caution. However, the low beta, attractive dividend, and decent profitability may justify a hold for investors focused on income and long‑term stability, provided they are comfortable with the medium‑level sector and regulatory risks.
Given the combination of bearish price action, a valuation gap relative to DCF, and debt‑related dividend sustainability questions, the short‑term outlook leans toward caution. However, the low beta, attractive dividend, and decent profitability may justify a hold for investors focused on income and long‑term stability, provided they are comfortable with the medium‑level sector and regulatory risks.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below key moving averages (20‑day and 50‑day)
- Negative MACD histogram indicating bearish momentum
- Significant overvaluation relative to DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Attractive dividend yield of 4.6 % with moderate payout ratio
- Low beta (0.07) suggesting limited market volatility
- Medium debt load that could pressure dividend sustainability
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable earnings growth and solid operating margins
- Diversified geographic footprint across several Asian markets
- Persistent valuation gap that may require price correction
Key Metrics & Analysis
Financial Health
Revenue Growth11.60%
Profit Margin39.24%
P/E Ratio12.8
ROE6.24%
ROA0.69%
P/B Ratio0.9
Op. Cash FlowNT$5.6B
Industry P/E17.1
Technical Analysis
TrendBearish
RSI45.3
SupportNT$37.60
ResistanceNT$40.85
MA 20NT$39.60
MA 50NT$39.93
MA 200NT$42.20
MACDBearish
VolumeIncreasing
Fear & Greed Index78.16
Valuation
Fair ValueNT$6.29
Target PriceNT$45.00
Upside/Downside14.94%
GradeOvervalued
TypeValue
Dividend Yield4.60%
Risk Assessment
Beta0.07
Volatility14.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.